INNOVUS PHARMACEUTICALS, INC.: 10-Q filed 2012-05-10
What INNOVUS PHARMACEUTICALS, INC. reported in its quarterly report filed 2012-05-10 (fiscal Q1 2012): 16 published measures, 41 facts as tagged in accession 0001144204-12-027544.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-05-10
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001144204-12-027544 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All INNOVUS PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 59,961 | USD | |
| At 2011-12-31 | 25,014 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -203,027 | USD | |
| At 2011-12-31 | -142,767 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 59,961 | USD | |
| At 2011-12-31 | 25,014 | USD | |
| At 2011-03-31 | 5,785 | USD | |
| At 2010-12-31 | 1,650 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -60,260 | USD | 91 |
| 2008-10-31 to 2012-03-31 | -2,413,805 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | -24,526 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -52,553 | USD | 91 |
| 2008-10-31 to 2012-03-31 | -277,539 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | -15,868 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 87,500 | USD | 91 |
| 2008-10-31 to 2012-03-31 | 337,500 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | 20,003 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | -2,413,805 | USD | |
| At 2011-03-31 | -24,526 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 59,961 | USD | |
| At 2011-12-31 | 25,014 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -3,983 | USD | 91 |
| 2008-10-31 to 2012-03-31 | -95,268 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | -4,320 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 234,062 | USD | |
| At 2011-12-31 | 138,855 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 56,277 | USD | 91 |
| 2008-10-31 to 2012-03-31 | 2,318,537 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | 20,206 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2008-10-31 to 2012-03-31 | 78,960 | USD | 1248 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-03-31 | 2,606,195 | USD | |
| At 2011-12-31 | 2,606,331 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | -60,260 | USD | 91 |
| 2008-10-31 to 2012-03-31 | -2,413,805 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | -24,526 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 56,277 | USD | 91 |
| 2008-10-31 to 2012-03-31 | 284,712 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | 20,206 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-03-31 | 3,724 | USD | 91 |
| 2008-10-31 to 2012-03-31 | 5,411 | USD | 1248 |
| 2011-01-01 to 2011-03-31 | 4,500 | USD | 90 |
Inspect the source
- Entity
- INNOVUS PHARMACEUTICALS, INC. / CIK 0001411879
- Captured
- SEC response SHA-256
e77a101a672b8634c33f41442578c32e719835a043b28e20b379158f9e2f8bab
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001411879.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))